McKee MD - Search Results

1

Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation.

Hariharan V, Klarquist J, Reust MJ, Koshoffer A, McKee MD, Boissy RE, Le Poole IC. Hariharan V, et al. Among authors: mckee md. J Invest Dermatol. 2010 Jan;130(1):211-20. doi: 10.1038/jid.2009.214. J Invest Dermatol. 2010. PMID: 19657355 Free article.

2

Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells.

Klarquist J, Barfuss A, Kandala S, Reust MJ, Braun RK, Hu J, Dilling DF, McKee MD, Boissy RE, Love RB, Nishimura MI, Le Poole IC. Klarquist J, et al. Among authors: mckee md. Am J Pathol. 2009 Dec;175(6):2463-72. doi: 10.2353/ajpath.2009.090525. Epub 2009 Nov 5. Am J Pathol. 2009. PMID: 19893037 Free PMC article.

3

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment.

Harlin H, Meng Y, Peterson AC, Zha Y, Tretiakova M, Slingluff C, McKee M, Gajewski TF. Harlin H, et al. Cancer Res. 2009 Apr 1;69(7):3077-85. doi: 10.1158/0008-5472.CAN-08-2281. Epub 2009 Mar 17. Cancer Res. 2009. PMID: 19293190 Free PMC article.

4

Recognition of carcinoembryonic antigen peptide and heteroclitic peptide by peripheral blood T lymphocytes.

Brown ME, Miao H, McKee MD. Brown ME, et al. Among authors: mckee md. J Immunother. 2007 Apr;30(3):350-8. doi: 10.1097/CJI.0b013e31802b5005. J Immunother. 2007. PMID: 17414326

5

Identification of a hepatitis C virus-reactive T cell receptor that does not require CD8 for target cell recognition.

Callender GG, Rosen HR, Roszkowski JJ, Lyons GE, Li M, Moore T, Brasic N, McKee MD, Nishimura MI. Callender GG, et al. Among authors: mckee md. Hepatology. 2006 May;43(5):973-81. doi: 10.1002/hep.21157. Hepatology. 2006. PMID: 16628627

6

Antigen recognition and T-cell biology.

Nishimura MI, Roszkowski JJ, Moore TV, Brasic N, McKee MD, Clay TM. Nishimura MI, et al. Among authors: mckee md. Cancer Treat Res. 2005;123:37-59. doi: 10.1007/0-387-27545-2_2. Cancer Treat Res. 2005. PMID: 16211865 Review.

7

CD8-independent tumor cell recognition is a property of the T cell receptor and not the T cell.

Roszkowski JJ, Yu DC, Rubinstein MP, McKee MD, Cole DJ, Nishimura MI. Roszkowski JJ, et al. Among authors: mckee md. J Immunol. 2003 Mar 1;170(5):2582-9. doi: 10.4049/jimmunol.170.5.2582. J Immunol. 2003. PMID: 12594285

8

T cell immunotherapy.

McKee MD, Fichera A, Nishimura MI. McKee MD, et al. Front Biosci. 2007 Jan 1;12:919-32. doi: 10.2741/2114. Front Biosci. 2007. PMID: 17127349 Review.

9

Effects of interleukin 2 therapy on lymphocyte magnesium levels.

McKee MD, Cecco SA, Niemela JE, Cormier J, Kim CJ, Steinberg SM, Rehak NN, Elin RJ, Rosenberg SA. McKee MD, et al. J Lab Clin Med. 2002 Jan;139(1):5-12. doi: 10.1067/mlc.2002.120361. J Lab Clin Med. 2002. PMID: 11873239 Clinical Trial.

10

Targeted therapy for solid tumors: current status.

Zureikat AH, McKee MD. Zureikat AH, et al. Among authors: mckee md. Surg Oncol Clin N Am. 2008 Apr;17(2):279-301, vii-viii. doi: 10.1016/j.soc.2008.01.004. Surg Oncol Clin N Am. 2008. PMID: 18375353 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

576 results

Search Page